These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 2832506

  • 21. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I, Becherer JD, Alsenz J, De la Hera A, Lao Z, Tsoukas CD, Lambris JD.
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [Abstract] [Full Text] [Related]

  • 22. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
    Krych M, Hourcade D, Atkinson JP.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4353-7. PubMed ID: 1827918
    [Abstract] [Full Text] [Related]

  • 23. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM, Rakstang JK, Young KA, Hinshelwood J, Aslam M, Robertson A, Gipson MG, Sarrias MR, Moore WT, Meagher M, Karp D, Lambris JD, Perkins SJ, Holers VM.
    Biochemistry; 2001 May 22; 40(20):5931-41. PubMed ID: 11352728
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.
    Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S.
    J Exp Med; 1988 Feb 01; 167(2):664-9. PubMed ID: 2450163
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H, Kinoshita T, Webster CB, Holers VM.
    J Immunol; 1994 Jul 15; 153(2):789-95. PubMed ID: 8021513
    [Abstract] [Full Text] [Related]

  • 28. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH, Fischer E, Kazatchkine MD, Lenoir GM, Lefevre-Delvincourt C, Revillard JP.
    Scand J Immunol; 1987 Jun 15; 25(6):587-98. PubMed ID: 3037684
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
    Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, Perkins SJ.
    J Mol Biol; 2008 Jan 04; 375(1):102-18. PubMed ID: 18028942
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).
    Fingeroth JD, Clabby ML, Strominger JD.
    J Virol; 1988 Apr 04; 62(4):1442-7. PubMed ID: 2831405
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.
    Ahearn JM, Hayward SD, Hickey JC, Fearon DT.
    Proc Natl Acad Sci U S A; 1988 Dec 04; 85(23):9307-11. PubMed ID: 2848261
    [Abstract] [Full Text] [Related]

  • 34. Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21) which is due to alternative exon usage.
    Barel M, Balbo M, Frade R.
    Mol Immunol; 1998 Nov 04; 35(16):1025-31. PubMed ID: 10068037
    [Abstract] [Full Text] [Related]

  • 35. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW, Cahill JM, Rosen MD, Kennedy CA, Bonaccio ET, Morris MJ, Wilson JG, Klickstein LB, Fearon DT.
    J Exp Med; 1989 Mar 01; 169(3):847-63. PubMed ID: 2564414
    [Abstract] [Full Text] [Related]

  • 36. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD.
    Eur J Immunol; 1992 May 01; 22(5):1123-31. PubMed ID: 1315687
    [Abstract] [Full Text] [Related]

  • 37. Complement receptors.
    Holers VM.
    Year Immunol; 1989 May 01; 4():231-40. PubMed ID: 2538973
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
    Molina H, Perkins SJ, Guthridge J, Gorka J, Kinoshita T, Holers VM.
    J Immunol; 1995 May 15; 154(10):5426-35. PubMed ID: 7730644
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.